Cerity Partners LLC - PROTAGONIST THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Cerity Partners LLC ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$187,900
-43.3%
11,265
-6.0%
0.00%0.0%
Q2 2023$331,164
+20.1%
11,9900.0%0.00%0.0%
Q1 2023$275,770
+199.8%
11,990
+3.0%
0.00%0.0%
Q2 2022$92,00011,6400.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders